Autoimmune Diseases  >>  gevokizumab (VPM087)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
gevokizumab (VPM087) / Novartis
NCT00998699: Study of the Effects of XOMA 052 on Insulin Production in Subjects With Well Controlled Type 1 Diabetes

Completed
2
22
Europe
Xoma 052, Placebo
XOMA (US) LLC, Juvenile Diabetes Research Foundation
Type 1 Diabetes
08/13
08/13
NCT01788033: Effects of XOMA 052 on Insulin Production in Type 1 Diabetes

Completed
2
22
Europe
XOMA 052, Placebo
University of Zurich, XOMA (US) LLC
Diabetes Mellitus Type 1
09/13
09/13
NCT00777816: Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Active, Stable, Moderate to Severe Rheumatoid Arthritis

Suspended
2
18
US
XOMA 052, Placebo
XOMA (US) LLC
Rheumatoid Arthritis
10/14
 

Download Options